LEXEO THERAPEUTICS INC. COMMON STOCK

NASDAQ: LXEO (Lexeo Therapeutics, Inc.)

Last update: 2 days ago, 7:31PM

14.02

0.06 (0.43%)

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Bearish Mixed
Biotechnology (Global) Bearish Mixed
Stock Lexeo Therapeutics, Inc. Bullish -

Similar Stocks

Stock Market Cap DY P/E P/B
-
ASND 8 B - - -
ACLX 3 B - - 5.43
AUTL 1 B - - 6.27
ANL 480 M - - 8.36
ADAP 286 M - - 12.15

Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.

Sector Healthcare
Industry Biotechnology

Ownership

Name Date Shares Held
Omega Fund Management, Llc 31 Mar 2024 2,355,904
Artal Group S.A. 31 Mar 2024 801,716
Blackstone Inc. 31 Dec 2023 696,110
Vestal Point Capital, Lp 31 Mar 2024 175,000
Cornell University 31 Mar 2024 126,258
52 Weeks Range
9.00 - 22.33
High 24.00 (RBC Capital, 71.18%) Buy
Median 24.00 (71.18%)
Average 24.00 (71.18%)
Total 1 Buy
Firm Date Target Price Call Price @ Call
RBC Capital 12 Mar 2024 24.00 (71.18%) Buy 15.69
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
TOWNSEND RICHARD NOLAN - 13.56 -5,000 -67,800
Aggregate Net Quantity -5,000
Aggregate Net Value ($) -67,800
Aggregate Avg. Buy ($) -
Aggregate Avg. Sell ($) 13.56
Name Holder Date Type Quantity Price Value ($)
TOWNSEND RICHARD NOLAN Officer 13 May 2024 Automatic sell (-) 5,000 13.56 67,800
TOWNSEND RICHARD NOLAN Officer 13 May 2024 Option execute 5,000 - -

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2024 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No data